EMD-42816
SARS-CoV-1 5' proximal stem-loop 5
EMD-42816
Single-particle7.1 Å
Deposition: 13/11/2023Map released: 20/12/2023
Last modified: 13/03/2024
Sample Organism:
SARS coronavirus Tor2
Sample: SARS-CoV-1 5' proximal stem-loop 5
Fitted models: 8uyp
Deposition Authors: Kretsch RC
,
Xu L ,
Zheludev IN,
Zhou X ,
Huang R,
Nye G,
Li S,
Zhang K,
Chiu W ,
Das R
Sample: SARS-CoV-1 5' proximal stem-loop 5
Fitted models: 8uyp
Deposition Authors: Kretsch RC
,
Xu L ,
Zheludev IN,
Zhou X ,
Huang R,
Nye G,
Li S,
Zhang K,
Chiu W ,
Das R
Tertiary folds of the SL5 RNA from the 5' proximal region of SARS-CoV-2 and related coronaviruses.
Kretsch RC ,
Xu L ,
Zheludev IN,
Zhou X ,
Huang R,
Nye G,
Li S,
Zhang K,
Chiu W ,
Das R
(2024) PNAS , 121 , e2320493121 - e2320493121
,
Xu L ,
Zheludev IN,
Zhou X ,
Huang R,
Nye G,
Li S,
Zhang K,
Chiu W ,
Das R
(2024) PNAS , 121 , e2320493121 - e2320493121
Grant Support:
- National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS): R35GM122579 (United States)
- Howard Hughes Medical Institute (HHMI): (United States)
- National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS): U24GM129541 (United States)
- National Science Foundation (NSF, United States): GRFPDGE1656518 (United States)
- Ministry of Science and Technology (MoST, China): 2022YFC2303700 (China)
- Ministry of Science and Technology (MoST, China): 2022YFA1302700 (China)
- Other private: BioX Bowes fellowship (United States)
- Other private: BioX Interdisciplinary Initiative Program (United States)
- Other private: ChEM-H COVID-19 Drug and Vaccine Prototyping seed grant (United States)
- Department of Energy (DOE, United States): Coronavirus CARES Act (United States)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): #U19AI171421 (United States)